Effects of transdermal testosterone gel on bone turnover markers and bone mineral density in hypogonadal men

Clinical Endocrinology

Volumn 54, Issue 6, 2001, Pages 739-750

  Wang, Christina ^a   Swerdloff, Ronald S ^a   Iranmanesh, Ali ^b   Dobs, Adrian ^c   Snyder, Peter J ^d   Cunningham, Glenn ^e   Matsumoto, Alvin M ^f   Weber, Thomas ^g   Berman, Nancy ^a  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

^f UNIVERSITY OF WASHINGTON   (United States)

^g DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; AMINO TERMINAL TELOPEPTIDE; CREATINE; OSTEOCALCIN; PEPTIDE; PROCOLLAGEN; TESTOSTERONE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BONE DENSITY; BONE DEVELOPMENT; BONE MINERAL; BONE TURNOVER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG FORMULATION; ESTRADIOL BLOOD LEVEL; GEL; HIP; HORMONE SUBSTITUTION; HUMAN; HYPOGONADISM; MALE; MULTICENTER STUDY; OSTEOLYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SPINE; TRANSDERMAL PATCH;

ADMINISTRATION, CUTANEOUS; ADULT; AGED; ALKALINE PHOSPHATASE; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; BONE DENSITY; BONE REMODELING; CALCIUM; COLLAGEN; COLLAGEN TYPE I; CREATININE; DRUG ADMINISTRATION SCHEDULE; ESTRADIOL; GELS; HUMANS; HYPOGONADISM; MALE; MIDDLE AGED; OSTEOCALCIN; PEPTIDES; PHOSPHORUS; PROCOLLAGEN; PROSPECTIVE STUDIES; TESTOSTERONE;

EID: 0035725618     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2001.01271.x     Document Type: Article

References (42)

1. Effect of testosterone on bone density and bone metabolism in adolescent male hypogonadism
2. Pathogenesis of vertebral crush fractures in men
3. Long-term effect of testosterone therapy on bone mineral density in hypogonadal men
4. Regulation of interleukin-6, osteoclastogenesis and bone mass by androgens: The role of the androgen receptor
5. Osteoporosis in men
6. Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency
7. Effect of testosterone and estradiol in a man with aromatase deficiency
8. Site-specific effect of testosterone on bone mineral density in male hypogonadism
9. Identification of androgen receptors in normal human osteoblastic-like cells
10. Low bone mass in hypogonadal males. Effect of testosterone substitution therapy, a densitometric study
11. Effect of testosterone and venesection on spinal and peripheral bone mineral in six hypogonadal men with hemochromatosis
12. Osteoporosis in men with idiopathic hypogonadotropic hypogonadism
13. Parathyroid hormone for the prevention of bone loss induced by estrogen deficiency
14. The effects of testosterone on osteoporosis in men
15. Direct modulation by androgens of the response of human bone cells (Sa OS-2) to human parathyroid hormone (PTH) and PTH-related protein
16. Osteoporosis in men with hyperprolactinemic hypogonadism
17. Treatment of isolated hypogonadotropic hypogonadism effect on bone mineral density and bone turnover
18. Testosterone deficiency is common in men with hip fracture after simple falls
19. Osteoporosis in men: Diagnosis, pathophysiology and prevention
20. Testosterone deficiency as a risk factor for hip fractures in men: A ease-control study
21. Studies of the mechanism by which androgens enhance mitogenesis and differentiation in bone cells
22. Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism
23. Effects of testosterone replacement therapy on cortical and trabecular bone mineral density, vertebral body area and paraspinal muscle area in hypogonadal men
24. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens
25. Anabolic effects of parathyroid hormone on bone
26. Effects of testosterone replacement therapy in old hypogonadal males: A preliminary study
27. Osteoporosis in men
28. Androgens and bone: Clinical aspects
29. Androgen receptors in osteoblastic-like cell lines
30. Comparison of the effects of estrogen alone and estrogen plus androgen on biochemical markers of bone formation and resorption in postmenopausal women
31. Osteoporosis in men: Epidemiology, pathophysiology, and treatment possibilities
32. Osteoporosis in men
33. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man
34. Effect of testosterone treatment on bone mineral density in men over 65 years of age
35. Does hypogonadism contribute to the occurrence of a minimal trauma hip fracture in elderly men?
36. Long term pharmacokinetics of transdermal testosterone gel in hypogonadal men
37. Effects of testosterone supplementation in the aging male
38. Differential effects of androgens on cortical bone histomorphometry in gonadectomized male and female rats
39. Sublingual testosterone replacement improves muscle mass and strength and decreases bone resorption and increases bone formation markers in hypogonadal men - A Clinical Research Center Study
40. Pharmacokinetics of transdermal testosterone gel in hypogonadal men: Application of gel at one site versus four sites
41. Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in liypogonadel men
42. The effects of androgen deficiency on murine bone remodeling and bone mineral density are mediated in cells of the osteoblastic lineage